Schizophrenia Research Study

Researchers at Neurobehavioral Research, Inc. are conducting a study to assess if a study medication is safe and effective in improving cognition in individuals with schizophrenia.

Fast Facts

Diagnosed with Schizophrenia

Individuals ages
18-60

Compensation Provided

Conducted in Cedarhurst, NY

Study Background

This study aims to explore potential treatments for cognitive deficits in patients with schizophrenia.

Schizophrenia is a serious mental health disorder that affects how we think, feel, and behave. One of the biggest challenges we face with schizophrenia is cognitive impairments, which can include problems with memory, attention, and decision-making. These issues can make it difficult for us to manage daily activities and maintain relationships. While current medications can help with some symptoms of schizophrenia, there is still a need for better treatments that specifically target these cognitive problems.

To address this need, our team at Neurobehavioral Research, Inc. is conducting a study to test a new medication aimed at improving cognitive function in individuals with schizophrenia. The goal of our study is to find out if this new drug can safely enhance memory, attention, and other cognitive skills, offering us a new option for managing the cognitive symptoms of the disorder. By examining the medication’s safety and effectiveness, we hope to discover better ways to support ourselves and others with schizophrenia in our everyday lives.

Study Background

This study aims to explore potential treatments for cognitive deficits in patients with schizophrenia.

Schizophrenia is a serious mental health disorder that affects how we think, feel, and behave. One of the biggest challenges we face with schizophrenia is cognitive impairments, which can include problems with memory, attention, and decision-making. These issues can make it difficult for us to manage daily activities and maintain relationships. While current medications can help with some symptoms of schizophrenia, there is still a need for better treatments that specifically target these cognitive problems.

To address this need, our team at Neurobehavioral Research, Inc. is conducting a study to test a new medication aimed at improving cognitive function in individuals with schizophrenia. The goal of our study is to find out if this new drug can safely enhance memory, attention, and other cognitive skills, offering us a new option for managing the cognitive symptoms of the disorder. By examining the medication’s safety and effectiveness, we hope to discover better ways to support ourselves and others with schizophrenia in our everyday lives.

Additional Information

This study is being done to determine if a new medication is both safe and effective at improving cognitive function in individuals with schizophrenia.

You may qualify for a study if you meet the following criteria.

Inclusion Criteria:

  • Ages 18-60
  • Diagnosed with schizophrenia
  • Willing to try new medication
  • No history of head trauma
  • No seizure disorder
  • Do not live in Staten Island or New Jersey

If you participate in this study, you will attend four clinic visits and five phone visits over an eight-week treatment period. At the clinic visits, a clinician will evaluate your progress, blood samples will be collected, and an ECG will be performed. You will also complete rating scales to assess the progress of your treatment.

As a participant, you can receive up to $4,000 in compensation.

There is no cost for you to participate in our research study. There are also several options for transportation: company car, Uber, or reimbursement for travel.